Global Health Limited at its board meeting held on November 9, 2013, has approved execution of definitive agreements along with other papers necessary for jointly incorporation of Special Purpose Vehicle (SPY) with M/s DLF Limited. Purpose of entering into the agreement: Under the definitive agreement, the Company and DLF Limited will jointly incorporate a Special Purpose Vehicle ("SPV") in the form of public limited company to design, construct, develop, equip, operate and manage super specialty hospitals, clinics and health care centers with other related ancillary medical facilities and services. The Company and DLF Limited would subscribe 50% stake each in the proposed SPY.

Significant terms of the Agreements are: SPY to be jointly incorporated by the Company and DLF Limited public limited company. Shareholding: SPY will have 50:50 equity shareholding of the Company and DLF Limited on a Fully Diluted Basis. Initial Subscribed Capital: INR 2,000,000 or such other nominal amount as may be mutually agreed.

Board Composition: Minimum 6 directors - 3 GHL Nominee Directors (at leasl 1 shall be an Executive Director) and 3 DLF Nominee Directors, (all will be Non-Executive Directors). Until Dr. Trehan/his affiliates (family, entities controlled by them and family trust, if any) continue to hold or control 16% of the shareholding of GHL, GHL Nominee Director will be the chairperson of SPV. the event Dr. Trehan's/his affiliates' shareholding in GHL drops below 16% but DLF continues to hold 50% shareholding in the SPV, then, a DLF Nominee Director will be the chairperson of the SPY.

However, such chairperson will not have the right to a casting vote. In the event the shareholding of Dr. Trehan/his affiliates in GHL falls below 16% and DLF's shareholding in the SPV fal1s below 50%, then, the Board of the SPV will appoint the chairperson of the SPY. Such chairperson will not have the right to a casting vote.